# FDA recall D-498-2013

> **Aurobindo Pharma USA Inc** · Class III · drug recall initiated 2013-04-09.

## Product

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810  Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

## Reason for recall

Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

## Distribution

Nationwide

## Key facts

- **Recall number:** D-498-2013
- **Recalling firm:** Aurobindo Pharma USA Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-04-09
- **Report date:** 2013-06-05
- **Termination date:** 2014-01-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Plainsboro, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-498-2013

## Citation

> AI Analytics. FDA recall D-498-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-498-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
